Beacon Angels — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
GelMEDIXgelmedix.comFeb 2026
GelMEDIX is a Cambridge-based biotech developing injectable hydrogel-based cell and gene therapies for vision-restoring retinal treatment.
BiotechCambridge, US
Max Cotler(Executive Officer)inNasim Annabi(Director)Reza Dana(Director)Arthur Driscoll(Executive Officer, Director)
BoardMichael Cima(Director)Parinaz Motamedy(Director)
Co-investorsBoston Harbor AngelsSafar Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.